Izumi H, Kurokawa J, Yokoyama E
Department of Urology, Kitasato University School of Medicine.
Hinyokika Kiyo. 1990 Nov;36(11):1277-85.
The effect of local administration of thrombin via a newly devised four-way balloon indwelling catheter was investigated on 89 patients who underwent transurethral resection of the prostate (TURP). The catheter was introduced into the bladder immediately after TURP, the balloon was inflated with sterile water and mild moist sponge traction was applied to seal the bladder neck for 15 minutes. At the same time, the thrombin solution, 5,000 U in 5 ml of saline, was then injected into the prostatic fossa via the newly added infusion channel to promote early hemostasis. The results were compared with those of 36 randomized control patients, who were treated with the conventional three-way balloon catheter of the same size. The results obtained with this new device were favorable, showing significantly less postoperative hemorrhage in the thrombin infusion group than in the control group. In 7 of 89 thrombin infused patients, serum FDP revealed mild elevation for 2 hours after TURP. In 2 of these 7 patients FDP was closely correlated with thrombin infusion. However, no adverse reactions were observed in any patient in the thrombin infusion group. In conclusion, our new device to administer locally the thrombin solution is effective and safe for management of bleeding after TURP.
通过一种新设计的四腔球囊留置导管局部应用凝血酶的效果,在89例行经尿道前列腺切除术(TURP)的患者中进行了研究。TURP术后立即将导管插入膀胱,用无菌水充盈球囊,并施加轻度湿海绵牵引以封闭膀胱颈15分钟。与此同时,将5000单位凝血酶溶于5毫升生理盐水中,经新增的输注通道注入前列腺窝以促进早期止血。将结果与36例采用相同尺寸传统三腔球囊导管治疗的随机对照患者的结果进行比较。使用这种新装置获得的结果良好,凝血酶输注组术后出血明显少于对照组。在89例接受凝血酶输注的患者中,有7例患者在TURP术后2小时血清纤维蛋白降解产物(FDP)轻度升高。在这7例患者中的2例,FDP与凝血酶输注密切相关。然而,凝血酶输注组的任何患者均未观察到不良反应。总之,我们局部应用凝血酶溶液的新装置对TURP术后出血的处理是有效且安全的。